Goldman Sachs Call 600 MUV2 20.06.../ DE000GQ2MAM9 /
17/05/2024 10:43:13 | Var.+0.090 | Denaro22:00:44 | Lettera22:00:44 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.810EUR | +12.50% | - Quantità in denaro: - |
- Quantità in lettera: - |
MUENCH.RUECKVERS.VNA... | 600.00 EUR | 20/06/2025 | Call |
GlobeNewswire
00:11
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importa...
GlobeNewswire
00:00
ADSK Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Act...
GlobeNewswire
17/05
NCLA Tells Department of Education Its Newest Student Loan Debt Cancellation Plan Is Unlawful
GlobeNewswire
17/05
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of...
GlobeNewswire
17/05
Lincoln National Corporation investors: Please contact the Portnoy Law Firm to recover your losses; ...
GlobeNewswire
17/05
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic ...
GlobeNewswire
17/05
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
17/05
Experience the Illicit Romance of 19th-Century with B.D. Anderson's "Forbidden Desires"
GlobeNewswire
17/05
Altus Group Terminates Proposed Acquisition of Situs Group’s Commercial Real Estate Valuation Servic...
GlobeNewswire
17/05
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
17/05
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors wit...